---
title: "Citius Oncology appoints Jonathan Peri as independent director, expands board to nine members"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295662190.md"
description: "Citius Oncology has appointed Jonathan Peri as an independent director, effective August 10, expanding its board to nine members. Peri serves as President of Manor College and previously held leadership roles at Neumann University and First State Bank."
datetime: "2026-08-12T12:06:46.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295662190.md)
  - [en](https://longbridge.com/en/news/295662190.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295662190.md)
generator: "portal-rs"
---

# Citius Oncology appoints Jonathan Peri as independent director, expands board to nine members

-   Citius Oncology appointed Jonathan Peri as an independent director, effective Aug. 10, expanding the board to nine members. \* Peri is President of Manor College, previously served as vice president and general counsel of Neumann University. \* He was lead advisory board director at First State Bank from 2021 to 2024. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Citius Oncology Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: NY24535) on August 12, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [CTOR.US](https://longbridge.com/en/quote/CTOR.US.md)

## Related News & Research

- [Bank of America Corp DE Acquires 3,834,946 Shares of Citius Oncology, Inc. $CTOR](https://longbridge.com/en/news/297744898.md)
- [Innate Pharma to Spotlight Oncology Pipeline at H.C. Wainwright Investor Conference](https://longbridge.com/en/news/297736839.md)
- [Alamar Biosciences appoints Robert Ragusa to board](https://longbridge.com/en/news/297691608.md)
- [Starling Oncology director Brad Hively to step down as vice chairman, not seek re-election in 2027](https://longbridge.com/en/news/297766159.md)
- [Tempus AI director Nadja West sells 3,000 shares worth $207,000](https://longbridge.com/en/news/297693362.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**